top of page

ACCELERATE

CLINICAL GENOMICS

OUR MISSION

Enable laboratories to launch clinical next generation genomics programs and promote collaboration for the advancement of medical science.

ABOUT US

Boston Lighthouse Innovations (BLI) was founded to commercialize the BioBeam Platform, leveraging advanced bioinformatics workflow expertise developed at The Massachusetts General Hospital Center for Integrated Diagnostics (MGH CID). The BioBeam Platform embodies commercial-grade solutions that optimize precision medicine programs and are built on a foundation of proven clinical applications.

OFFERINGS

The BioBeam Platform was designed for laboratory workflow and management, analytics, and reporting of next generation sequencing data.

-

BLI shares with MGH CID a goal to accelerate Clinical genomics.

OUR TECHNOLOGY

Our BioBeam Platform streamlines every aspect of a clinical next generation genomics (NGS) laboratory from accession, to providing clinical decision support, to final custom case signout.
Designed for precision and scalability, BioBeam integrates into clinical workflows, ensuring robust performance and regulatory compliance.

GET IN TOUCH

We’d love to discuss how the BioBeam Platform can accelerate clinical genomics in your laboratory...

bottom of page